Bennett Caughey, MD


06/2019 - Internal Medicine, UCSF Internal Medicine Residency
MD, 06/2016 - Medicine, UCSD School of Medicine
A.B., 06/2010 - Molecular and Cellular Biology, Harvard College
  1. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
  2. DNA methylation markers for diagnosis and prognosis of common cancers.
  3. MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients.
  4. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.
  5. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.
  6. Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
  7. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.